Sander, J., Janzen, N., Peter, M., Sander, S., Holtkamp, U., Schwahn, B., Mayatepek, E., Trefz, F.K. and Das, A.M. (2006) Newborn Screening or Hepatorenal Tyrosinemia: Tandem Mass Spectrometric Quantification of Succinylacetone. Clinical Chemistry, 52, 482-487.
https://doi.org/10.1373/clinchem.2005.059790

has been cited by the following article:

• TITLE: An Unusual and Previously Unreported Association between Tyrosinemia Type 1 and an Extremely Rare Variation of Congenital Cystic Dilatation: TODANI’s VI Cystic Duct Cyst: Report of a Case

  AUTHORS: Laila Essabar, Hajar Rghouda, Saloua Dahri, Layachi Chabraoui, Latifa Chat, Yamna Kriouile

  KEYWORDS: Cystic Duct, Choledochal Cyst, Tyrosinemia, Cholestasis, NTBC, Neonate

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.4 No.12, December 14, 2016

  ABSTRACT: Cystic duct cysts are rare lesions, and type VI of TODANI’s modified classification is the rarest subtype with only sporadic case reports in the literature. The following report describes the coexistence of this entity and type 1 tyrosinemia in a one month-old infant referred to our department for etiological investigations of prolonged neonatal cholestasis. To the best of our knowledge, we report herein the first case in the literature describing this association. Cystic duct abnormalities should be considered in the differential diagnosis of neonatal cholestases, however further investigations should be performed to exclude associated life-threatening conditions such as metabolic disorders including tyrosinemia.